Item Type | Name |
Concept
|
CD24 Antigen
|
Concept
|
Antigen Presentation
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Ki-67 Antigen
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
T-Cell Antigen Receptor Specificity
|
Concept
|
Carcinoembryonic Antigen
|
Concept
|
Proliferating Cell Nuclear Antigen
|
Concept
|
B-Cell Maturation Antigen
|
Concept
|
Prostate-Specific Antigen
|
Concept
|
Ki-1 Antigen
|
Concept
|
HLA-A2 Antigen
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
Academic Article
|
[Gallbladder cancer: immunohistochemical expression of CA-19-9, epithelial membrane antigen, dupan-2 and carcinoembryonic antigen].
|
Academic Article
|
[Proliferating cell nuclear antigen (PCNA) in patients with malabsorption syndrome: comparative study with morphometric parameters].
|
Academic Article
|
Proliferating cell nuclear antigen in gallbladder carcinoma.
|
Academic Article
|
Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas.
|
Academic Article
|
Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells.
|
Academic Article
|
[Immunohistochemical expression of the carcinoembryonic antigen in gallbladder cancer].
|
Academic Article
|
Biological activity of celecoxib in the bronchial epithelium of current and former smokers.
|
Academic Article
|
Lung cancer stem cell: fancy conceptual model of tumor biology or cornerstone of a forthcoming therapeutic breakthrough?
|
Academic Article
|
[Proliferating cell nuclear antigen in cervical cancer and precursor lesions].
|
Academic Article
|
[Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
|
Academic Article
|
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
|
Academic Article
|
Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?
|
Academic Article
|
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.
|
Academic Article
|
STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.
|
Academic Article
|
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
|
Academic Article
|
Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.
|
Academic Article
|
Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma.
|
Academic Article
|
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
|
Academic Article
|
Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer.
|
Academic Article
|
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients.
|
Academic Article
|
A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer.
|
Academic Article
|
Expression of PD-1 and PD-L1 in thymic epithelial neoplasms.
|
Academic Article
|
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.
|
Academic Article
|
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.
|
Academic Article
|
Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
|
Academic Article
|
Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
|
Academic Article
|
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade.
|
Academic Article
|
B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density.
|
Academic Article
|
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer.
|
Academic Article
|
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer.
|
Concept
|
AC133 Antigen
|
Concept
|
B7 Antigens
|
Concept
|
B7-H1 Antigen
|
Concept
|
CTLA-4 Antigen
|
Academic Article
|
Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer.
|
Academic Article
|
Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.
|
Academic Article
|
Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer.
|
Academic Article
|
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy.
|
Academic Article
|
A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma.
|
Academic Article
|
Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer.
|
Academic Article
|
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee.
|
Academic Article
|
STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype.
|
Academic Article
|
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.
|
Academic Article
|
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma.
|
Academic Article
|
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC.
|
Academic Article
|
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment.
|
Academic Article
|
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion.
|
Academic Article
|
eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancer.
|
Academic Article
|
PD-L1 as a biomarker of response to immune-checkpoint inhibitors.
|
Academic Article
|
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).
|
Academic Article
|
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial.
|
Academic Article
|
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.
|
Academic Article
|
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC.
|
Academic Article
|
Global analysis of shared T?cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
|
Academic Article
|
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.
|
Academic Article
|
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma.
|
Academic Article
|
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.
|
Academic Article
|
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy.
|
Academic Article
|
The immunogenomic landscape of resected intrahepatic cholangiocarcinoma.
|
Academic Article
|
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer.
|
Academic Article
|
Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer.
|
Academic Article
|
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC.
|
Academic Article
|
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk.
|
Academic Article
|
Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment.
|
Academic Article
|
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee.
|
Academic Article
|
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
|
Academic Article
|
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of?Recurrence in Stage I Non-Small Cell Lung Cancer.
|
Academic Article
|
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
|
Academic Article
|
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
|
Academic Article
|
Quantitative multiplexed imaging technologies for single-cell analysis to assess predictive markers for immunotherapy in thoracic immuno-oncology: promises and challenges.
|
Academic Article
|
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides.
|